Fred E. Regnier

Regnier founded Novilytic and joined as the Chief Executive Officer in 2014. The company was originally founded to develop medical device blood cards and methods and is successfully producing that product today. He has co-founded five analytical science companies including PerSeptive Biosystems, BG Medicine, Quadraspec and Perfinity Bioscience.

Dr. Regnier held the J.H. Law Distinguished Professor of Chemistry position at Purdue University. He has co-authored 306 peer-reviewed publications in the fields of chromatography, proteomics, and metabolomics and holds 47 patents in analytical and diagnostic science. Dr. Regnier was the Chief Scientific Officer at PBIO for 3 years, directing an R&D staff of ~100.